Cisplatin
- Generic Name
- Cisplatin
- Brand Names
- Platinol
- Drug Type
- Small Molecule
- Chemical Formula
- Cl2H6N2Pt
- CAS Number
- 15663-27-1
- Unique Ingredient Identifier
- Q20Q21Q62J
- Background
Cisplatin, cisplatinum or cis-diamminedichloroplatinum(II) (CDDP) is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas and germ cell tumors. It was the first member of its class, which now also includes carboplatin and oxaliplatin.
- Indication
For the treatment of metastatic testicular tumors, metastatic ovarian tumors and advanced bladder cancer.
- Associated Conditions
- Advanced Ovarian Cancer, Ovarian Cancer Metastatic, Advanced Bladder cancer, Advanced Testicular cancer, Metastatic Testicular cancer
- Associated Therapies
- -
Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-01-24
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 30
- Registration Number
- NCT00002913
- Locations
- 🇺🇸
Gynecologic Oncology Group of Arizona, Phoenix, Arizona, United States
Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-01-23
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 756
- Registration Number
- NCT00005838
- Locations
- 🇺🇸
M D Anderson Cancer Center, Houston, Texas, United States
S9912 Combination Chemo in Stage III Ovarian Cancer,
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-01-04
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 68
- Registration Number
- NCT00003896
- Locations
- 🇺🇸
Munson Medical Center, Traverse City, Michigan, United States
🇺🇸David C. Pratt Cancer Center at St. John's Mercy, St. Louis, Missouri, United States
🇺🇸Montana Cancer Center at St. Patrick Hospital and Health Sciences Center, Missoula, Montana, United States
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-10-01
- Lead Sponsor
- Temple University
- Registration Number
- NCT00002522
- Locations
- 🇺🇸
Fox Chase - Temple Cancer Center, Philadelphia, Pennsylvania, United States
Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-10-01
- Lead Sponsor
- Temple University
- Registration Number
- NCT00002521
- Locations
- 🇺🇸
Fox Chase - Temple Cancer Center, Philadelphia, Pennsylvania, United States
Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2011-08-03
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 48
- Registration Number
- NCT00003690
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2014-01-09
- Lead Sponsor
- Case Comprehensive Cancer Center
- Target Recruit Count
- 4
- Registration Number
- NCT00041015
- Locations
- 🇺🇸
Ireland Cancer Center, Cleveland, Ohio, United States
Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2014-01-06
- Lead Sponsor
- Herbert Irving Comprehensive Cancer Center
- Registration Number
- NCT00024271
- Locations
- 🇺🇸
Herbert Irving Comprehensive Cancer Center at Columbia University, New York, New York, United States
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-05-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 546
- Registration Number
- NCT00052910
- Locations
- 🇺🇸
Cancer Research UK Medical Oncology Unit at Churchill Hospital & Weatherall Institute of Molecular Medicine - Oxford, Salem, Ohio, United States
🇺🇸Kaiser Foundation Hospital - San Rafael, San Rafael, California, United States
🇺🇸Kinston Medical Specialists, Kinston, North Carolina, United States
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2014-12-31
- Lead Sponsor
- Gynecologic Oncology Group
- Target Recruit Count
- 35
- Registration Number
- NCT00005840
- Locations
- 🇺🇸
Gynecologic Oncology Group, Philadelphia, Pennsylvania, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.